Report Detail

Pharma & Healthcare Global and Japan Hypertension Drug Market Insights, Forecast to 2026

  • RnM4203491
  • |
  • 14 September, 2020
  • |
  • Global
  • |
  • 133 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Hypertension Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Hypertension Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Hypertension Drug Market Size Growth Rate by Type
    • 1.4.2 Calcium Channel Blockers
    • 1.4.3 Diuretics
    • 1.4.4 Beta Blockers Vasodilators
    • 1.4.5 Angiotensin Converting Enzyme Inhibitors
    • 1.4.6 Alpha Blockers
    • 1.4.7 Angiotensin Receptor Blockers
    • 1.4.8 Renin Inhibitors
  • 1.5 Market by Application
    • 1.5.1 Global Hypertension Drug Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Private clinic
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Hypertension Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Hypertension Drug Revenue 2015-2026
    • 2.1.2 Global Hypertension Drug Sales 2015-2026
  • 2.2 Global Hypertension Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Hypertension Drug Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Hypertension Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Hypertension Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Hypertension Drug Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Hypertension Drug Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Hypertension Drug Revenue Forecast by Region (2021-2026)

3 Global Hypertension Drug Competitor Landscape by Players

  • 3.1 Global Top Hypertension Drug Sales by Manufacturers
    • 3.1.1 Global Hypertension Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Hypertension Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Hypertension Drug Manufacturers by Revenue
    • 3.2.1 Global Hypertension Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Hypertension Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Hypertension Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Hypertension Drug Revenue in 2019
    • 3.2.5 Global Hypertension Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Hypertension Drug Price by Manufacturers
  • 3.4 Global Hypertension Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Hypertension Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Hypertension Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Hypertension Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Hypertension Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Hypertension Drug Sales by Type (2015-2020)
    • 4.1.2 Global Hypertension Drug Revenue by Type (2015-2020)
    • 4.1.3 Hypertension Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Hypertension Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Hypertension Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Hypertension Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Hypertension Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Hypertension Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Hypertension Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Hypertension Drug Sales by Application (2015-2020)
    • 5.1.2 Global Hypertension Drug Revenue by Application (2015-2020)
    • 5.1.3 Hypertension Drug Price by Application (2015-2020)
  • 5.2 Hypertension Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Hypertension Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Hypertension Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Hypertension Drug Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Hypertension Drug Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Hypertension Drug Sales YoY Growth 2015-2026
    • 6.1.2 Japan Hypertension Drug Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Hypertension Drug Market Share in Global Market 2015-2026
  • 6.2 Japan Hypertension Drug Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Hypertension Drug Players by Sales (2015-2020)
    • 6.2.2 Japan Top Hypertension Drug Players by Revenue (2015-2020)
  • 6.3 Japan Hypertension Drug Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Hypertension Drug Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Hypertension Drug Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Hypertension Drug Price by Type (2015-2020)
  • 6.4 Japan Hypertension Drug Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Hypertension Drug Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Hypertension Drug Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Hypertension Drug Price Forecast by Type (2021-2026)
  • 6.5 Japan Hypertension Drug Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Hypertension Drug Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Hypertension Drug Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Hypertension Drug Price by Application (2015-2020)
  • 6.6 Japan Hypertension Drug Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Hypertension Drug Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Hypertension Drug Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Hypertension Drug Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Hypertension Drug Market Size YoY Growth 2015-2026
  • 7.2 North America Hypertension Drug Market Facts & Figures by Country
    • 7.2.1 North America Hypertension Drug Sales by Country (2015-2020)
    • 7.2.2 North America Hypertension Drug Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Hypertension Drug Market Size YoY Growth 2015-2026
  • 8.2 Europe Hypertension Drug Market Facts & Figures by Country
    • 8.2.1 Europe Hypertension Drug Sales by Country
    • 8.2.2 Europe Hypertension Drug Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Hypertension Drug Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Hypertension Drug Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Hypertension Drug Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Hypertension Drug Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Hypertension Drug Market Size YoY Growth 2015-2026
  • 10.2 Latin America Hypertension Drug Market Facts & Figures by Country
    • 10.2.1 Latin America Hypertension Drug Sales by Country
    • 10.2.2 Latin America Hypertension Drug Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Hypertension Drug Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Hypertension Drug Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Hypertension Drug Sales by Country
    • 11.2.2 Middle East and Africa Hypertension Drug Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Lupin Limited
    • 12.1.1 Lupin Limited Corporation Information
    • 12.1.2 Lupin Limited Description and Business Overview
    • 12.1.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Lupin Limited Hypertension Drug Products Offered
    • 12.1.5 Lupin Limited Recent Development
  • 12.2 Novartis AG
    • 12.2.1 Novartis AG Corporation Information
    • 12.2.2 Novartis AG Description and Business Overview
    • 12.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Novartis AG Hypertension Drug Products Offered
    • 12.2.5 Novartis AG Recent Development
  • 12.3 Daiichi - Sankyo
    • 12.3.1 Daiichi - Sankyo Corporation Information
    • 12.3.2 Daiichi - Sankyo Description and Business Overview
    • 12.3.3 Daiichi - Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Daiichi - Sankyo Hypertension Drug Products Offered
    • 12.3.5 Daiichi - Sankyo Recent Development
  • 12.4 Pfizer Inc
    • 12.4.1 Pfizer Inc Corporation Information
    • 12.4.2 Pfizer Inc Description and Business Overview
    • 12.4.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Pfizer Inc Hypertension Drug Products Offered
    • 12.4.5 Pfizer Inc Recent Development
  • 12.5 Ranbaxy Laboratories Limited
    • 12.5.1 Ranbaxy Laboratories Limited Corporation Information
    • 12.5.2 Ranbaxy Laboratories Limited Description and Business Overview
    • 12.5.3 Ranbaxy Laboratories Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Ranbaxy Laboratories Limited Hypertension Drug Products Offered
    • 12.5.5 Ranbaxy Laboratories Limited Recent Development
  • 12.6 Sanofi S.A
    • 12.6.1 Sanofi S.A Corporation Information
    • 12.6.2 Sanofi S.A Description and Business Overview
    • 12.6.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Sanofi S.A Hypertension Drug Products Offered
    • 12.6.5 Sanofi S.A Recent Development
  • 12.7 AstraZeneca Plc
    • 12.7.1 AstraZeneca Plc Corporation Information
    • 12.7.2 AstraZeneca Plc Description and Business Overview
    • 12.7.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 AstraZeneca Plc Hypertension Drug Products Offered
    • 12.7.5 AstraZeneca Plc Recent Development
  • 12.8 Johnson & Johnson Ltd
    • 12.8.1 Johnson & Johnson Ltd Corporation Information
    • 12.8.2 Johnson & Johnson Ltd Description and Business Overview
    • 12.8.3 Johnson & Johnson Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Johnson & Johnson Ltd Hypertension Drug Products Offered
    • 12.8.5 Johnson & Johnson Ltd Recent Development
  • 12.9 Boehringer Ingelheim
    • 12.9.1 Boehringer Ingelheim Corporation Information
    • 12.9.2 Boehringer Ingelheim Description and Business Overview
    • 12.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Boehringer Ingelheim Hypertension Drug Products Offered
    • 12.9.5 Boehringer Ingelheim Recent Development
  • 12.10 Merck & Co.
    • 12.10.1 Merck & Co. Corporation Information
    • 12.10.2 Merck & Co. Description and Business Overview
    • 12.10.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Merck & Co. Hypertension Drug Products Offered
    • 12.10.5 Merck & Co. Recent Development
  • 12.11 Lupin Limited
    • 12.11.1 Lupin Limited Corporation Information
    • 12.11.2 Lupin Limited Description and Business Overview
    • 12.11.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Lupin Limited Hypertension Drug Products Offered
    • 12.11.5 Lupin Limited Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Hypertension Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Hypertension Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Hypertension Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hypertension Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Hypertension Drug market is segmented into
    Calcium Channel Blockers
    Diuretics
    Beta Blockers Vasodilators
    Angiotensin Converting Enzyme Inhibitors
    Alpha Blockers
    Angiotensin Receptor Blockers
    Renin Inhibitors

    Segment by Application, the Hypertension Drug market is segmented into
    Hospital
    Private clinic
    Others

    Regional and Country-level Analysis
    The Hypertension Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Hypertension Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Hypertension Drug Market Share Analysis
    Hypertension Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hypertension Drug business, the date to enter into the Hypertension Drug market, Hypertension Drug product introduction, recent developments, etc.
    The major vendors covered:
    Lupin Limited
    Novartis AG
    Daiichi - Sankyo
    Pfizer Inc
    Ranbaxy Laboratories Limited
    Sanofi S.A
    AstraZeneca Plc
    Johnson & Johnson Ltd
    Boehringer Ingelheim
    Merck & Co.


    Summary:
    Get latest Market Research Reports on Hypertension Drug. Industry analysis & Market Report on Hypertension Drug is a syndicated market report, published as Global and Japan Hypertension Drug Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Hypertension Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,034.00
    4,551.00
    6,067.99
    3,309.40
    4,964.09
    6,618.79
    407,191.20
    610,786.80
    814,382.40
    286,915.20
    430,372.80
    573,830.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report